Skip to main content

Borregaard ASA: Shares for employees 2026

2 March 2026: Borregaard ASA (“Borregaard”, OSE ticker: BRG) Reference is made to the stock exchange notices of 9 and 16 February regarding the shares to employees’ programme. Today Borregaard transferred in total 212,596 shares to the 503 employees who participated in this year’s programme. After this transfer Borregaard owns 55,867 treasury shares. Contact:Lotte Kvinlaug, Investor Relations Officer, +47 922 86 909

Continue reading

Share buyback programme – week 9

Nasdaq CopenhagenEuronext DublinLondon Stock ExchangeDanish Financial Supervisory AuthorityOther stakeholders Date        2 March 2026 Share buyback programme – week 9 The share buyback programme runs in the period 2 February 2026 up to and including 8 May 2026, see company announcement of 30 January 2026. During the period the bank will thus buy back its own shares for a total of up to DKK 500 million under the programme, but to a maximum of 600,000 shares. The programme is implemented in compliance with EU Commission Regulation No. 596/2014 of 16 April 2014 and EU Commission Delegated Regulation No. 2016/1052 of 8 March 2016, which together constitute the “Safe Harbour” regulation. The following transactions have been made under the programme:Date Number of shares Average purchase price (DKK) Total purchased under the programme (DKK)Total...

Continue reading

Share repurchase programme: Transactions of week 9 2026

The share repurchase programme runs as from 5 February 2026 and up to and including 29 January 2027 at the latest. In this period, Jyske Bank will acquire shares with a value of up to DKK 3 billion, cf. Corporate Announcement No. 11/2026 of 5 February 2026. The share repurchase programme is initiated and structured in compliance with the Market Abuse Regulation (Regulation (EU) No 596/2014) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (together with the Market Abuse Regulation, the “Safe Harbour Rules”). The following transactions have been made under the program:  Number of shares Average purchase price (DKK) Transaction value (DKK)Accumulated, previous announcement 157,902 956.36 151,011,16423 February 2026 12,671 962.34 12,193,83224 February 2026 12,731 945.80 12,040,91925 February 2026 12,344 953.33 11,767,90126...

Continue reading

Kosmos Energy Announces Fourth Quarter And Full Year 2025 Results

DALLAS, March 02, 2026 (GLOBE NEWSWIRE) — Kosmos Energy Ltd. (“Kosmos” or the “Company”) (NYSE/LSE: KOS) announced today its financial and operating results for the fourth quarter of 2025. For the quarter, the Company generated a net loss of $377 million, or $0.79 per diluted share. When adjusted for certain items that impact the comparability of results, the Company generated an adjusted net loss(1) of $78 million, or $0.16 per diluted share for the fourth quarter of 2025. FOURTH QUARTER 2025 AND POST QUARTER END HIGHLIGHTSZero lost-time injuries or total recordable injuries in 2025Net Production(2): ~67,900 barrels of oil equivalent per day (boepd), up ~4% versus third quarter 2025, with sales of ~62,900 boepdRevenues: $295 million, or $50.88 per boe (excluding the impact of derivative cash settlements)Production expense:...

Continue reading

STMicroelectronics to host investor calls on Cloud AI and Intelligent Sensing Enabling Physical AI

STMicroelectronics to host investor calls on Cloud AI and Intelligent Sensing Enabling Physical AI Geneva, March 2, 2026 – STMicroelectronics N.V. (“ST”) (NYSE: STM) will host two webcasts for investors and analysts in March 2026.“ST for Cloud AI”, hosted by Remi El-Ouazzane, President of ST’s MDRF Group. Conference call & webcast on March 9, 2026, at 3.30pm CET / 10.30am ET.“ST Intelligent Sensing Enabling the Physical AI”, hosted by Marco Cassis, President of ST’s APMS Group. Conference call & webcast on March 16, 2026, at 3.30pm CET / 10.30am ET.Presentations will be followed by a Q&A session. A live webcast (listen-only mode) of the conference will be accessible at ST’s website, https://investors.st.com, and will be available for replay. About STMicroelectronicsAt ST, we are 48,000 creators and makers...

Continue reading

Skyworks and MediaTek Showcase Early 6G FR3 and PC1 RF Front-End Innovations at MWC 2026

Live Demonstrations at MediaTek Hall 3, Stand 3D10 BARCELONA, Spain, March 02, 2026 (GLOBE NEWSWIRE) — Skyworks Solutions, Inc. (Nasdaq: SWKS) announced it will showcase an early 6G new FR3 frequency range RF front-end (RFFE) power amplifier at Mobile World Congress 2026 (MWC26), taking place in Barcelona from March 2–5, 2026. Presented in collaboration with MediaTek, the live demonstration highlights the companies’ continued efforts to advance next-generation wireless platforms and accelerate access to future 6G technologies. At MWC26 Hall 3, Stand 3D10, MediaTek will demonstrate a reference design that uses the SKYR60002 advanced 6G FR3 LNA and power amplifier module with integrated filters designed to support the new 6.425GHz to > 7 GHz spectrum supported in the latest 3GPP standard. The SKYR60002 6G FR3 LNA power amplifier...

Continue reading

Press release: Orange Business and Tech Mahindra to forge strategic partnership to accelerate end-to-end digital transformation for enterprise customers worldwide, focusing on AI, automation and secure digital platforms

Press releaseParis, 02 March 2026 Orange Business and Tech Mahindra to forge strategic partnership to accelerate end-to-end digital transformation for enterprise customers worldwide, focusing on AI, automation and secure digital platformsThis proposed 5-year partnership aims to fast-track next-generation solutions for international customers by combining Orange Business’ trusted leadership in networks, platforms, cloud and cybersecurity with Tech Mahindra’s strong integration expertise and agile delivery capabilities Orange Business to boost profitable growth thanks to strengthened competitiveness of its international operations and access to new markets through an ambitious go-to-market approach Tech Mahindra to benefit from economies of scale and leverage Orange’s trusted infrastructure and platforms to provide new value-added servicesOrange...

Continue reading

Paul Chaplin Steps Down as CEO of Bavarian Nordic

COPENHAGEN, Denmark, March 2, 2026 – Bavarian Nordic A/S (OMX: BAVA) announced today, that the Board of Directors has entered into an agreement with CEO, Paul Chaplin, who wishes to step down for personal reasons. Paul Chaplin will continue in his role for the remainder of 2026, or until a successor has been identified. The Board of Directors has initiated the process to identify a new CEO. Paul Chaplin has been with Bavarian Nordic since 1999 and was appointed CEO in 2014. He has led the development of the Company’s smallpox and mpox vaccine, representing a significant contribution to public health globally. Under his leadership, Bavarian Nordic has grown from a small research-based company with a single government customer to a large vaccine manufacturer with strong commercial operations in key markets. This growth has been made possible...

Continue reading

Space42 and Viasat to Share Progress on Equatys at Mobile World Congress

Companies advance plans for global system architecture and shared infrastructure for Direct-to-Device and other Advanced Mobile Satellite Services BARCELONA, Spain, March 02, 2026 (GLOBE NEWSWIRE) — Space42, the UAE-based AI-powered SpaceTech company, and Viasat, Inc., a global leader in satellite communications, will discuss continued progress toward their planned direct-to-device (D2D) infrastructure and offer an early look at the priorities for Equatys, the companies’ forthcoming joint entity, during a co-hosted program at Mobile World Congress in Barcelona this week. The program marks the first public showcase of Equatys’ technical direction and commercial vision, reflecting its ambition to accelerate global D2D adoption.   This event brings together policymakers, regulators, and industry leaders to explore how...

Continue reading

Press Release: Sanofi’s rilzabrutinib earns orphan drug designation in Japan for IgG4-related disease

Sanofi’s rilzabrutinib earns orphan drug designation in Japan for IgG4-related diseaseDesignation based on positive data from a phase 2 study of rilzabrutinib in IgG4-RD Third global orphan drug designation for rilzabrutinib in IgG4-RD, underpinning Sanofi’s commitment to rare immune-mediated diseasesParis, March 2, 2026 – The Ministry of Health, Labour and Welfare (MHLW) in Japan has granted orphan drug designation to rilzabrutinib, a novel, oral, reversible covalent Bruton’s tyrosine kinase (BTK) inhibitor, for IgG4-related disease (IgG4-RD). There is still unmet medical need and limited treatment options in Japan for IgG4-RD, a rare, progressive, immune-mediated chronic condition in which the immune system attacks various tissues and organs leading to serious damage. The MHLW grants orphan designation to medicines that address...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.